リトラクションノート:ホーミングシステムは,治療用T細胞を脳がんに標的とする

Heba Samaha^1,2,3,4, Antonella Pignata^2,3,4, Kristen Fousek^2,3,4,5

¹Children's Cancer Hospital Egypt-57357, Cairo, Egypt.

Nature

|February 22, 2019

まとめ

この研究は撤回され,もはや有効とは考えられない. 撤回理由の詳細については,公式の撤回通知を参照してください.

科学分野:

科学出版の倫理
研究の整合性

背景:

科学的な誠実さを維持する上で撤回の重要性
撤回された研究の意味を理解する.

研究の目的:

この記事の撤回について読者に知らせるため
読み手は,付属の撤回通知を参照してください.

主な方法:

商品の取り消しに関する通知
公式の撤回声明を引用しています.

主要な成果:

問題の記事は正式に撤回されました.
撤回通知には,撤回理由の詳細が記載されています.

結論:

撤回された記事は引用したり,頼りにするべきではありません.
詳細については,撤回通知を参照してください.

さらに関連する動画

05:22

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

3.9K

11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.2K

関連する概念動画

01:27

Tumor Immunotherapy

1.3K

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

1.3K

02:57

Targeted Cancer Therapies

8.3K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...